Guidelines suggest patient self-testing and management of oral anticoagulation are viable for selected patients with proper training, but require further evidence for widespread UK implementation.
Answers are grounded in this paper and cite their sources.
Supports self-testing and management for selected trained patients on oral anticoagulation; extends evidence while leaving UK cost-effectiveness unresolved.
There is a limited evidence base for self-testing and -management for oral anticoagulation management. Available data suggest that these are credible models for a significant minority of patients if underpinned by structured training and follow-up. The guidelines presented are necessarily consensual and outline procedures for patient selection, training, product procurement, product maintenance, quality assurance procedures, dosage adjustment and clinical supervision. The cost-effectiveness of these models remains to be elucidated within the UK. Further data on both health economic and clinical outcomes are required from UK based studies before widespread implementation of self-testing and management can be recommended on a wider scale.
No takes yet. Share an insight, caveat, or question.
Fitzmaurice et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: